Radioautographic Determination of Cellular Localization of Radioactive Mercury (203Hg) Chlormerodrin in Brain Tumors
- 9 November 1967
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 277 (19) , 1006-1007
- https://doi.org/10.1056/nejm196711092771905
Abstract
BLAU and Bender1 in 1960 first reported on the use of radioactive mercury (203Hg) chlormerodrin for the localization of brain tumors. Until recently evidence of the area of deposition of this material in Central-nervous-system lesions was not available. Recently, it has been demonstrated in primary brain tumors of the astrocytoma type that the radioactive mercury appears in or on the neoplastic cells.2 This paper will demonstrate that in a nonmalignant, intracranial meningioma and in a metastatic brain tumor the cellular localization of radioactive mercury is similar to that demonstrated in brain tumors of neuroglial origin. The methods and materials . . .This publication has 0 references indexed in Scilit: